{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T05:26:22Z","timestamp":1790745982800,"version":"4.1.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP 18K19656"],"award-info":[{"award-number":["JP 18K19656"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Oral Biosciences"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.job.2019.02.002","type":"journal-article","created":{"date-parts":[[2019,3,5]],"date-time":"2019-03-05T12:10:19Z","timestamp":1551787819000},"page":"95-98","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":83,"title":["Bone metastasis: Interaction between cancer cells and bone microenvironment"],"prefix":"10.1016","volume":"61","author":[{"given":"Toru","family":"Hiraga","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.job.2019.02.002_bib1","doi-asserted-by":"crossref","first-page":"6243s","DOI":"10.1158\/1078-0432.CCR-06-0931","article-title":"Clinical features of metastatic bone disease and risk of skeletal morbidity","volume":"12","author":"Coleman","year":"2006","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.job.2019.02.002_bib2","first-page":"1832","article-title":"Use of the stromal cell-derived factor-1\/CXCR4 pathway in prostate cancer metastasis to bone","volume":"62","author":"Taichman","year":"2002","journal-title":"Cancer Res"},{"key":"10.1016\/j.job.2019.02.002_bib3","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S1535-6108(03)00132-6","article-title":"A multigenic program mediating breast cancer metastasis to bone","volume":"3","author":"Kang","year":"2003","journal-title":"Cancer Cell"},{"key":"10.1016\/j.job.2019.02.002_bib4","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1359\/JBMR.041109","article-title":"Skeletal localization and neutralization of the SDF-1(CXCL12)\/CXCR4 axis blocks prostate cancer metastasis and growth in osseous sites in vivo","volume":"20","author":"Sun","year":"2004","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.job.2019.02.002_bib5","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1038\/nri.2017.53","article-title":"Adult haematopoietic stem cell niches","volume":"17","author":"Crane","year":"2017","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.job.2019.02.002_bib6","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1172\/JCI43414","article-title":"Human prostate cancer metastases target the hematopoietic stem cell niche to establish footholds in mouse bone marrow","volume":"121","author":"Shiozawa","year":"2011","journal-title":"J Clin Invest"},{"key":"10.1016\/j.job.2019.02.002_bib7","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1038\/nrc867","article-title":"Metastasis to bone: causes, consequences and therapeutic opportunities","volume":"2","author":"Mundy","year":"2002","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.job.2019.02.002_bib8","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/S0959-8049(97)10131-9","article-title":"Morphology of bone metastasis","volume":"34","author":"Hiraga","year":"1998","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.job.2019.02.002_bib9","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1007\/s00774-008-0857-1","article-title":"Involvement of cell-cell and cell-matrix interactions in bone destruction induced by metastatic MDA-MB-231 human breast cancer cells in nude mice","volume":"26","author":"Nakamura","year":"2008","journal-title":"J Bone Miner Metab"},{"key":"10.1016\/j.job.2019.02.002_bib10","doi-asserted-by":"crossref","first-page":"2919","DOI":"10.1002\/1097-0142(20000615)88:12+<2919::AID-CNCR7>3.0.CO;2-Z","article-title":"Biochemical markers and skeletal metastases","volume":"88","author":"Demers","year":"2000","journal-title":"Cancer"},{"key":"10.1016\/j.job.2019.02.002_bib11","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1002\/pros.10349","article-title":"Intraosseous growth of human prostate cancer in implanted adult human bone: relationship of prostate cancer cells to osteoclasts in osteoblastic metastatic lesions","volume":"58","author":"Yonou","year":"2004","journal-title":"Prostate"},{"key":"10.1016\/j.job.2019.02.002_bib12","doi-asserted-by":"crossref","first-page":"4238","DOI":"10.1158\/0008-5472.CAN-11-3061","article-title":"Bone-derived IGF mediates crosstalk between bone and breast cancer cells in bony metastases","volume":"72","author":"Hiraga","year":"2012","journal-title":"Cancer Res"},{"key":"10.1016\/j.job.2019.02.002_bib13","first-page":"4418","article-title":"The bisphosphonate ibandronate promotes apoptosis in MDA-MB-231 human breast cancer cells in bone metastases","volume":"61","author":"Hiraga","year":"2001","journal-title":"Cancer Res"},{"key":"10.1016\/j.job.2019.02.002_bib14","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s00223-017-0353-5","article-title":"Bone-targeted therapies in cancer-induced bone disease","volume":"102","author":"Sousa","year":"2018","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.job.2019.02.002_bib15","doi-asserted-by":"crossref","first-page":"12665","DOI":"10.1016\/S0021-9258(18)67143-1","article-title":"Growth factors in bone matrix. Isolation of multiple types by affinity chromatography on heparin-Sepharose","volume":"261","author":"Hauschka","year":"1986","journal-title":"J Biol Chem"},{"key":"10.1016\/j.job.2019.02.002_bib16","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1038\/nm.1979","article-title":"TGF-\u03b21\u2013induced migration of bone mesenchymal stem cells couples bone resorption with formation","volume":"15","author":"Tang","year":"2009","journal-title":"Nat Med"},{"key":"10.1016\/j.job.2019.02.002_bib17","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1038\/nm.2793","article-title":"Matrix IGF-1 maintains bone mass by activation of mTOR in mesenchymal stem cells","volume":"18","author":"Xian","year":"2012","journal-title":"Nat Med"},{"key":"10.1016\/j.job.2019.02.002_bib18","doi-asserted-by":"crossref","first-page":"4985","DOI":"10.1200\/JCO.2009.27.5040","article-title":"Small is beautiful: insulin-like growth factors and their role in growth, development, and cancer","volume":"28","author":"Maki","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.job.2019.02.002_bib19","doi-asserted-by":"crossref","first-page":"2602","DOI":"10.1002\/ijc.21653","article-title":"Inhibition of bone-derived insulin-like growth factors by a ligand-specific antibody suppresses the growth of human multiple myeloma in the human adult bone explanted in NOD\/SCID mouse","volume":"118","author":"Araki","year":"2006","journal-title":"Int J Cancer"},{"key":"10.1016\/j.job.2019.02.002_bib20","doi-asserted-by":"crossref","first-page":"6570","DOI":"10.1158\/0008-5472.CAN-05-1448","article-title":"Insulin-like growth factor-I receptor expression regulates neuroblastoma metastasis to bone","volume":"66","author":"van Golen","year":"2006","journal-title":"Cancer Res"},{"key":"10.1016\/j.job.2019.02.002_bib21","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1158\/1078-0432.CCR-09-0982","article-title":"Targeting of bone-derived insulin-like growth factor-II by a human neutralizing antibody suppresses the growth of prostate cancer cells in a human bone environment","volume":"16","author":"Kimura","year":"2010","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.job.2019.02.002_bib22","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1172\/JCI3523","article-title":"TGF-beta signaling blockade inhibits PTHrP secretion by breast cancer cells and bone metastases development","volume":"103","author":"Yin","year":"1999","journal-title":"J Clin Invest"},{"key":"10.1016\/j.job.2019.02.002_bib23","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/j.1349-7006.2006.00357.x","article-title":"Ki26894, a novel transforming growth factor-b type I receptor kinase inhibitor, inhibits in vitro invasion and in vivo bone metastasis of a human breast cancer cell line","volume":"98","author":"Ehata","year":"2007","journal-title":"Cancer Sci"},{"key":"10.1016\/j.job.2019.02.002_bib24","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1158\/0008-5472.CAN-05-2012","article-title":"Stimulation of cyclooxygenase-2 expression by bone-derived transforming growth factor-beta enhances bone metastases in breast cancer","volume":"66","author":"Hiraga","year":"2006","journal-title":"Cancer Res"},{"key":"10.1016\/j.job.2019.02.002_bib25","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.ccr.2010.12.022","article-title":"Tumor-derived Jagged1 promotes osteolytic bone metastasis of breast cancer by engaging Notch signaling in bone cells","volume":"19","author":"Sethi","year":"2011","journal-title":"Cancer Cell"},{"key":"10.1016\/j.job.2019.02.002_bib26","doi-asserted-by":"crossref","first-page":"3523","DOI":"10.3390\/ijms19113523","article-title":"Hypoxic microenvironment and metastatic bone disease","volume":"19","author":"Hiraga","year":"2018","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.job.2019.02.002_bib27","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/nature13034","article-title":"Direct measurement of local oxygen concentration in the bone marrow of live animals","volume":"508","author":"Spencer","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.job.2019.02.002_bib28","doi-asserted-by":"crossref","first-page":"4157","DOI":"10.1158\/0008-5472.CAN-06-2355","article-title":"Hypoxia and hypoxia-inducible factor-1 expression enhance osteolytic bone metastases of breast cancer","volume":"67","author":"Hiraga","year":"2007","journal-title":"Cancer Res"},{"key":"10.1016\/j.job.2019.02.002_bib29","first-page":"2013","article-title":"Antitumor effect of TAT-oxygen-dependent degradation-caspase-3 fusion protein specifically stabilized and activated in hypoxic tumor cells","volume":"62","author":"Harada","year":"2002","journal-title":"Cancer Res"},{"key":"10.1016\/j.job.2019.02.002_bib30","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.stem.2012.05.007","article-title":"Cancer stem cells: current status and evolving complexities","volume":"10","author":"Visvader","year":"2012","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.job.2019.02.002_bib31","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/s13045-018-0605-5","article-title":"The biology and role of CD44 in cancer progression: therapeutic implications","volume":"11","author":"Chen","year":"2018","journal-title":"J Hematol Oncol"},{"key":"10.1016\/j.job.2019.02.002_bib32","doi-asserted-by":"crossref","first-page":"4112","DOI":"10.1158\/0008-5472.CAN-12-3801","article-title":"Cancer stem-like cell marker CD44 promotes bone metastases by enhancing tumorigenicity, cell motility, and hyaluronan production","volume":"73","author":"Hiraga","year":"2013","journal-title":"Cancer Res"},{"key":"10.1016\/j.job.2019.02.002_bib33","doi-asserted-by":"crossref","first-page":"2962","DOI":"10.3892\/ol.2016.4985","article-title":"Comparable roles of CD44v8-10 and CD44s in the development of bone metastases in a mouse model","author":"Hiraga","year":"2016","journal-title":"Oncol Lett"},{"key":"10.1016\/j.job.2019.02.002_bib34","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1002\/ijc.29921","article-title":"EpCAM expression in breast cancer cells is associated with enhanced bone metastasis formation","volume":"138","author":"Hiraga","year":"2016","journal-title":"Int J Cancer"},{"key":"10.1016\/j.job.2019.02.002_bib35","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1517\/13543784.2016.1142972","article-title":"Targeted agents in preclinical and early clinical development for the treatment of cancer bone metastases","volume":"25","author":"Hiraga","year":"2016","journal-title":"Expert Opin Investig Drugs"}],"container-title":["Journal of Oral Biosciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1349007919300064?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1349007919300064?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T14:02:40Z","timestamp":1778594560000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1349007919300064"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":35,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["S1349007919300064"],"URL":"https:\/\/doi.org\/10.1016\/j.job.2019.02.002","relation":{},"ISSN":["1349-0079"],"issn-type":[{"value":"1349-0079","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bone metastasis: Interaction between cancer cells and bone microenvironment","name":"articletitle","label":"Article Title"},{"value":"Journal of Oral Biosciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.job.2019.02.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Japanese Association for Oral Biology. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}